OUR PRODUCTS

MOBILE APPS

GENERAL INFO

GLUE

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Monte Rosa Therapeutics (GLUE) Earnings Date & Reports

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GLUE is expected to report earnings to rise 5.56% to -37 cents per share on November 06

Monte Rosa Therapeutics GLUE Stock Earnings Reports

Q3'25

Est.

$-0.38

Q2'25

Beat

by $0.02

Q1'25

Beat

by $1.01

Q4'24

Missed

by $0.54

Q3'24

Beat

by $0.18

The last earnings report on August 07 showed earnings per share of -35 cents, beating the estimate of -37 cents. With 83.34K shares outstanding, the current market capitalization sits at 269.41M.

View a ticker or compare two or three

Compare

GLUE

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For GLUE
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GLUE showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

321 Harrison Avenue

Phone

+1 617 949-2643

Employees

133

Web

https://www.monterosatx.com